Development of cancer-targeted liposome with viral proteins

开发含有病毒蛋白的癌症靶向脂质体

基本信息

  • 批准号:
    19390508
  • 负责人:
  • 金额:
    $ 12.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2007
  • 资助国家:
    日本
  • 起止时间:
    2007 至 2009
  • 项目状态:
    已结题

项目摘要

Targeted liposomes can be broadly defined as liposomes that are engineered to interact with a particular population of cells with the objective of delivering a payload or increasing their retention within the targeted cell population. We previously identifided a Sindbis virus (SIN) strain which preferentially infects several cancers in vitro and in vivo without side effects. In this study, we have developed a cisplatin-encapsulating cancer-targeted liposome with the SIN protein and evaluated its cytotoxicity to cancers in vitro and in vivo. In vitro, the cisplatin-encapsulating cancer-targeted liposome has exhibited higher cytotoxicity to cancer cells than the cisplatin-encapsulating non-targeted liposome. Mice injected with the cisplatin-encapsulating cancer-targeted liposome displayed rapid tumor regression. Thus, this finding that a cisplatin-encapsulating cancer-targeted liposome with the SIN protein selectively fused with cancer cells and sensitized cancer cells suggested the application of this cancer-targeted lipsome to cancer therapy.
靶向脂质体可以被广泛地定义为脂质体,其被设计成与特定细胞群相互作用,目的是提供有效载荷或增加其在靶向细胞群中的保留。我们先前鉴定了一种Sindbis病毒(SIN)毒株,它在体外和体内优先感染几种癌症而没有副作用。在这项研究中,我们开发了一种含有SIN蛋白的顺铂包封癌症靶向脂质体,并在体外和体内评估了其对癌症的细胞毒性。在体外实验中,顺铂包封的癌症靶向脂质体比顺铂包封的非靶向脂质体对癌细胞具有更高的细胞毒性。小鼠注射顺铂包封的靶向肿瘤脂质体后,肿瘤迅速消退。因此,顺铂包封的带有SIN蛋白的癌症靶向脂质体选择性地与癌细胞融合并致敏癌细胞的发现提示了这种癌症靶向脂质体在癌症治疗中的应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
  • DOI:
    10.1016/j.oraloncology.2009.09.002
  • 发表时间:
    2009-12
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Kengo Saito;H. Shirasawa;N. Isegawa;M. Shiiba;K. Uzawa;H. Tanzawa
  • 通讯作者:
    Kengo Saito;H. Shirasawa;N. Isegawa;M. Shiiba;K. Uzawa;H. Tanzawa
Oncolytic activity of Sindbis virus for oral cancer cells.
辛德比斯病毒对口腔癌细胞的溶瘤活性。
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kengo Saito;M.A.Imai;K.Uzawa;K.Ogawa;H.Tanzawa;H.Shirasawa
  • 通讯作者:
    H.Shirasawa
Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells.
  • DOI:
    10.1038/sj.bjc.6605209
  • 发表时间:
    2009-08-18
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UZAWA Katsuhiro其他文献

UZAWA Katsuhiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UZAWA Katsuhiro', 18)}}的其他基金

Development of novel strategy for molecular diagnosis/treatment via circular RNAs adsorbing cancer-associated miRNAs in peripheral blood and saliva from cancer patients
通过环状RNA吸附癌症患者外周血和唾液中与癌症相关的miRNA来开发分子诊断/治疗的新策略
  • 批准号:
    17K19743
  • 财政年份:
    2017
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of the radioresistance conquest reinforcement therapy by an EGFR/FGFR dual inhibitor.
开发 EGFR/FGFR 双重抑制剂的放射抗性征服强化疗法。
  • 批准号:
    23659937
  • 财政年份:
    2011
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Cancer-targeted liposome coupled to viral proteins for imaging cancer cells
与病毒蛋白偶联的癌症靶向脂质体用于癌细胞成像
  • 批准号:
    22390380
  • 财政年份:
    2010
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of the method to select the most effective anti-cancer chemotherapy using in-house cDNA microarray
开发使用内部 cDNA 微阵列选择最有效的抗癌化疗的方法
  • 批准号:
    13470426
  • 财政年份:
    2001
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Isolation of a novel tumor suppressor gene on the Chromosome 7 associated with oral squamous cell carcinoma.
分离 7 号染色体上与口腔鳞状细胞癌相关的新型肿瘤抑制基因。
  • 批准号:
    11671976
  • 财政年份:
    1999
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza
任务 A66:低致病性季节性和大流行性流感小鼠模型
  • 批准号:
    9038198
  • 财政年份:
    2014
  • 资助金额:
    $ 12.06万
  • 项目类别:
Task A66: Mouse Model of Low-pathogenicity Seasonal and Pandemic Influenza
任务 A66:低致病性季节性和大流行性流感小鼠模型
  • 批准号:
    8930774
  • 财政年份:
    2014
  • 资助金额:
    $ 12.06万
  • 项目类别:
Differential gene expression induced by high and low pathogenicity influenza a virus infection in ducks
鸭高、低致病性甲型流感病毒感染诱导的差异基因表达
  • 批准号:
    377913-2009
  • 财政年份:
    2009
  • 资助金额:
    $ 12.06万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了